- Home
- BAK vs INVA Comparison
BAK vs INVA Comparison
Compare BAK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAK | INVA |
|---|---|---|
| Founded | 1972 | 1996 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.6B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | BAK | INVA |
|---|---|---|
| Price | $2.91 | $20.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $4.40 | ★ $36.60 |
| AVG Volume (30 Days) | ★ 901.4K | 768.6K |
| Earning Date | 11-11-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | N/A | ★ 1.52 |
| Revenue | ★ $13,841,708,237.00 | $388,521,000.00 |
| Revenue This Year | N/A | $13.23 |
| Revenue Next Year | $8.01 | $8.62 |
| P/E Ratio | ★ N/A | $13.52 |
| Revenue Growth | N/A | ★ 10.14 |
| 52 Week Low | $2.32 | $16.52 |
| 52 Week High | $5.10 | $22.76 |
Technical Indicators
Market Signals| Indicator | BAK | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 50.30 |
| Support Level | $2.83 | $20.44 |
| Resistance Level | $3.01 | $21.27 |
| Average True Range (ATR) | 0.12 | 0.55 |
| MACD | -0.01 | -0.19 |
| Stochastic Oscillator | 23.38 | 18.82 |
Price Performance
Historical ComparisonAbout BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.